- Should TB patients be quarantined in hospital or treated at home?
- What are the legal and ethical implications?
- How can the newest TB drugs best be managed to avoid triggering resistance in TB bacteria?
- What are the most effective ways of using the latest genomic techniques and information to combat TB?
These are just some of the questions that are becoming ever more critical as extensively drug-resistant (XDR) TB looms on Australia’s horizon—it’s already in Papua New Guinea. They are also examples of the issues to be discussed on Thursday 2 May and Friday 3 May at the first symposium of the new NHMRC-funded Centre of Research Excellence in Tuberculosis Control, located at the Centenary Institute.









